NORML Responds to National Academy of Sciences’ Marijuana Report

NORML | January 12, 2017

WASHINGTON, DC — The National Academy of Sciences, Engineering, and Medicine released a comprehensive report Thursday acknowledging that “conclusive or substantial evidence” exists for cannabis’ efficacy in patients suffering from chronic pain, and sharply criticized longstanding federal regulatory barriers to marijuana research – in particular “the classification of cannabis as a Schedule I substance” under federal law.

Authors of the report also addressed…